Relay Therapeutics Inc — Quarterly Cash Flow (NASDAQ:RLAY) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Total assets 930.12 M871.3 M799.36 M728.84 M670 M621.33 M Total liabilities 91.25 M93.5 M78.28 M63.18 M62.29 M54.27 M Total equity 838.86 M777.79 M721.08 M665.66 M607.71 M567.06 M Total liabilities & shareholders' equities 930.12 M871.3 M799.36 M728.84 M670 M621.33 M Total debt —————— Net debt ——————

Notizie

Relay Therapeutics stock hits 52-week high at 9.64 USD

Gli EPS di Relay hanno battuto le aspettative per 0,09$, il fatturato supera le previsioni

Relay earnings beat by $0.09, revenue topped estimates

Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates

Utili Relay Therapeutics sotto i riflettori dopo svolta FDA

Relay Therapeutics earnings in spotlight after FDA breakthrough

BB Biotech FY 2025: utili +660%, outlook 2026 cauto

Relay earnings in focus as FDA breakthrough fuels optimism

Le azioni di Relay Therapeutics salgono dopo lo status di Breakthrough Therapy della FDA

Relay Therapeutics stock rises after FDA grants Breakthrough Therapy status

FDA concede lo status di terapia innovativa al farmaco di Relay per il cancro al seno

FDA grants breakthrough therapy status to Relay’s breast cancer drug